Search results for "syringe pump"

Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-translational modifications.

Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike S2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-translational modifications.

An innovative approach to reveal the true breadth of environmental contamination

Dr. Bruce Conklin, UCSF, discusses the potential of genome engineering as a therapy for genetic diseases

With abundant data on plants, large animals and their activity, and carbon soil levels in the Amazon, Stanford research suggests that large animal diversity influences carbon stocks and contributes to climate change mitigation

SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell platform. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

Learn how selective antibodies help decipher an impaired autophagy pathway in spino-bulbar muscular atrophy

Chromatography experts share how the latest 2D-LC technology can benefit your pharmaceutical, food, or polymer analysis applications and more

We look back at the biggest stories and the best content from our analytical chemistry communities

New infographic from Vitl helps you get the most from your assays

Phenomenex CEO Fasha Mahjoor gives SelectScience an insight into his top tips for business success

Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth

By Anahita Pakzad, Gatan, Inc.

Find out how the Department of Laboratory Medicine at La Paz University Hospital is utilizing the Siemens DCA Vantage to improve diabetes monitoring and patient care

AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure